| Bioactivity | Tisolagiline (KDS2010) is a reversible MAO-B inhibitor used in Parkinson's disease research[1]. |
| Target | MAO-B |
| Name | Tisolagiline |
| CAS | 1894207-44-3 |
| Formula | C17H17F3N2O |
| Molar Mass | 322.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nam MH, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics. 2021 Jul;18(3):1729-1747. |